| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a60559e5784c59f0119d0cf1c3455f2b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-16 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-103
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-487
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-483
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6848 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92 |
| filingDate |
2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4b280d3b30269a6ef9e0735359e44fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65bb377b4d2400c805412f52968fa354 |
| publicationDate |
2015-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2015052611-A |
| titleOfInvention |
Biomarker and method for diagnosing multiple sclerosis |
| abstract |
A method for diagnosing and differentially diagnosing different types of multiple sclerosis is provided. Measure the intensity of a specific small molecule called a metabolite in a sample from a patient suffering from a clinically diagnosed relapsing-remitting or primary progressive form of multiple sclerosis And comparing their intensities with those found in the population of healthy individuals to identify multiple sclerosis markers. The method also provides for differential diagnosis of a subject suffering from relapsing-remitting multiple sclerosis from secondary progressive multiple sclerosis. [Selection figure] None |
| priorityDate |
2006-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |